Expression of TSHR on BM cells
| . | Cells within a group expressing TSHR, % . |
|---|---|
| Lymphocyte precursors | |
| CD11b− | 48.5 ± 5.1*,†,‡ |
| CD11b+ | 16.9 ± 4.7 |
| Monocyte precursors | |
| CD11b− | 34.7 ± 5.71,1,1-2,2,2-3,3,3-4,4,4-5,5,5-6,6,6-7,7,7-8,8,8-9,9,9-10,10,10-11,11,11-12,12,12-13,13,13-14,14,14-15,15,15-16,16,16-17,17,17-18,18,18-19,19,19-20,20,20-21,21,21-22,22,22-23,23,23-24,24,24-25,25,25-26,26,26-27,27,27-28,28,28-29,29,29-30,30,30-31,31,31-32,32,32-33,33,33-34,34,34-35,35,35-36,36,36-37,37,37-38,38,38-39,39,39-40,40,40-41,41,41-42,42,42-43,43,43-44,44,44-45,45,45-46,46,46-47,47,47-48,48,48-49,49,49-50,50,50-51,51,51-52,52,52-53,53,53-54,54,54-55,55,55-56,56,56-57,57,57-58,58,58-59,59,59-60,60,60-61,61,61-62,62,62-63,63,63-64,64,64-65,65,65-66,66,66-67,67,67-68,68,68-69,69,69-70,70,70-71,71,71-72,72,72-73,73,73-74,74,74-75,75,75-76,76,76-77,77,77-78,78,78-79,79,79-80,80,80-81,81,81-82,82,82-83,83,83-84,84,84-85,85,85-86,86,86-87,87,87-88,88,88-89,89,89-90,90,90-91,91,91-92,92,92-93,93,93-94,94,94-95,95,95-96,96,96-97,97,97-98,98,98-99,99,99-100,100,100-101,101,101-102,102,102-103,103,103-104,104,104-105,105,105-106,106,106-107,107,107-108,108,108-109,109,109-110,110,110-111,111,111-112,112,112-113,113,113-114,114,114-115,115,115-116,116,116-117,117,117-118,118,118-119,119,119-120,120,120-121,121,121-122,122,122-123,123,123-124,124,124-125,125,125-126,126,126-127,127,127-128,128,128-129,129,129-130,130,130-131,131,131-132,132,132-133,133,133-134,134,134-135,135,135-136,136,136-137,137,137-138,138,138-139,139,139-140,140,140-141,141,141-142,142,142-143,143,143-144,144,144-145,145,145-146,146,146-147,147,147-148,148,148-149,149,149-150,150,150-151,151,151-152,152,152-153,153,153-154,154-155 |
| CD11b+ | 24.3 ± 6.1 |
| Granulocyte precursors | |
| CD11b− | 19.7 ± 2.0 |
| CD11b+ | 17.4 ± 5.4 |
| . | Cells within a group expressing TSHR, % . |
|---|---|
| Lymphocyte precursors | |
| CD11b− | 48.5 ± 5.1*,†,‡ |
| CD11b+ | 16.9 ± 4.7 |
| Monocyte precursors | |
| CD11b− | 34.7 ± 5.71,1,1-2,2,2-3,3,3-4,4,4-5,5,5-6,6,6-7,7,7-8,8,8-9,9,9-10,10,10-11,11,11-12,12,12-13,13,13-14,14,14-15,15,15-16,16,16-17,17,17-18,18,18-19,19,19-20,20,20-21,21,21-22,22,22-23,23,23-24,24,24-25,25,25-26,26,26-27,27,27-28,28,28-29,29,29-30,30,30-31,31,31-32,32,32-33,33,33-34,34,34-35,35,35-36,36,36-37,37,37-38,38,38-39,39,39-40,40,40-41,41,41-42,42,42-43,43,43-44,44,44-45,45,45-46,46,46-47,47,47-48,48,48-49,49,49-50,50,50-51,51,51-52,52,52-53,53,53-54,54,54-55,55,55-56,56,56-57,57,57-58,58,58-59,59,59-60,60,60-61,61,61-62,62,62-63,63,63-64,64,64-65,65,65-66,66,66-67,67,67-68,68,68-69,69,69-70,70,70-71,71,71-72,72,72-73,73,73-74,74,74-75,75,75-76,76,76-77,77,77-78,78,78-79,79,79-80,80,80-81,81,81-82,82,82-83,83,83-84,84,84-85,85,85-86,86,86-87,87,87-88,88,88-89,89,89-90,90,90-91,91,91-92,92,92-93,93,93-94,94,94-95,95,95-96,96,96-97,97,97-98,98,98-99,99,99-100,100,100-101,101,101-102,102,102-103,103,103-104,104,104-105,105,105-106,106,106-107,107,107-108,108,108-109,109,109-110,110,110-111,111,111-112,112,112-113,113,113-114,114,114-115,115,115-116,116,116-117,117,117-118,118,118-119,119,119-120,120,120-121,121,121-122,122,122-123,123,123-124,124,124-125,125,125-126,126,126-127,127,127-128,128,128-129,129,129-130,130,130-131,131,131-132,132,132-133,133,133-134,134,134-135,135,135-136,136,136-137,137,137-138,138,138-139,139,139-140,140,140-141,141,141-142,142,142-143,143,143-144,144,144-145,145,145-146,146,146-147,147,147-148,148,148-149,149,149-150,150,150-151,151,151-152,152,152-153,153,153-154,154-155 |
| CD11b+ | 24.3 ± 6.1 |
| Granulocyte precursors | |
| CD11b− | 19.7 ± 2.0 |
| CD11b+ | 17.4 ± 5.4 |
Data are mean values ± SEM of 4 experiments. Statistical analyses were done using Student t test for unpaired observations.
P < .01 when compared to CD11b+ monocyte precursors and CD11b− granulocyte precursors.
P < .01 when compared to CD11b+lymphocyte precursors and CD11b+ granulocyte precursors.
P < .05 when compared to CD11b−monocyte precursors.
P < .01 when compared to CD11b+ lymphocyte precursors.
P < .025 when compared to CD11b− and CD11b+ granulocyte precursors.
P > .05 when compared to CD11b+ monocyte precursors.